(NYSE:MPW) by 3.1% during the second quarter, Holdings Channel reports. State Street Corp now owns 12,202,245 shares of the real estate investment trust's stock valued at $157,286,000 after buying an additional 811,784 shares during the last quarter. Envestnet Asset Management Inc. boosted its stake in Medical Properties Trust by 3.1% in the fourth quarter. Accern also gave news headlines about the real estate investment trust an impact score of 46.7338852971606 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the near term. Vanguard Group Inc. boosted its stake in Medical Properties Trust by 5.3% in the first quarter. HighTower Advisors LLC now owns 42,198 shares of the real estate investment trust's stock valued at $546,000 after buying an additional 10,140 shares during the last quarter. Finally, Teacher Retirement System of Texas boosted its position in Medical Properties Trust by 2.7% in the first quarter. Alliancebernstein L.P. now owns 2,433,780 shares of the real estate investment trust's stock valued at $31,371,000 after buying an additional 1,204,252 shares during the period.
On 5/25/2017 Medical Properties Trust announced a quarterly dividend of $0.24 7.5% with an ex dividend date of 6/13/2017 which will be payable on 7/14/2017. Schwab Charles Investment Management Inc. now owns 1,914,534 shares of the real estate investment trust's stock valued at $24,679,000 after buying an additional 176,666 shares during the period. Bank of New York Mellon Corp now owns 12,416,273 shares of the real estate investment trust's stock valued at $160,045,000 after buying an additional 5,493,706 shares during the last quarter.
Several institutional investors have recently added to or reduced their stakes in the stock.
Shares of Medical Properties Trust, Inc.
Shares of Medical Properties Trust (NYSE MPW) opened at 12.93 on Tuesday.
Trading was light with 136K shares changing hands on Thursday. Medical Properties Trust, Inc. The stock's 50-day moving average price is $13.00 and its 200-day moving average price is $13.03. The stock has a market capitalization of $4.14 billion, a P/E ratio of 15.468 and a beta of 0.89.
Medical Properties Trust (NYSE:MPW) last posted its quarterly earnings data on Thursday, May 4th. The real estate investment trust reported $0.33 EPS for the quarter, meeting analysts' consensus estimates of $0.33. The firm had revenue of $166.80 million for the quarter, compared to analyst estimates of $163.08 million. Envestnet Asset Management Inc. increased its stake in Medical Properties Trust by 3.1% in the fourth quarter. The firm's quarterly revenue was up 32.1% on a year-over-year basis. They expect $0.32 earnings per share, 0.00 % or $0.00 from last year's $0.32 per share. Medical Properties Trust updated its FY17 guidance to $1.29-1.31 EPS and its FY18 guidance to $1.42-1.46 EPS. Stockholders of record on Thursday, June 15th were paid a dividend of $0.24 per share. This represents a $0.96 annualized dividend and a dividend yield of 7.42%. The ex-dividend date was set for Tuesday the 13th of June 2017. Medical Properties Trust had a return on equity of 7.94% and a net margin of 41.79%.
COPYRIGHT VIOLATION NOTICE: This report was posted by Community Financial News and is the sole property of of Community Financial News. If you are reading this article on another publication, it was stolen and reposted in violation of United States & global copyright and trademark laws. The original version of this report can be read at https://www.com-unik.info/2017/07/30/medical-properties-trust-inc-mpw-shares-bought-by-naples-global-advisors-llc.html.
06/09/2017 - Medical Properties Trust, Inc. had its " rating reiterated by analysts at Jefferies. Stifel Nicolaus reissued a "hold" rating and issued a $13.00 price target on shares of Medical Properties Trust in a research note on Friday, July 28th. Jefferies maintained it with "Buy" rating and $16 target in Friday, June 9 report. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating and seven have assigned a buy rating to the company. Medical Properties Trust presently has an average rating of "Hold" and a consensus target price of $14.20.
In related news, CFO R Steven Hamner sold 85,000 shares of the firm's stock in a transaction on Wednesday, June 14th. The Tekla Capital Management Llc holds 1.01M shares with $12.40M value, up from 839,217 last quarter. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. As of February 24, 2017, the Company's portfolio consisted of 232 properties, including 215 facilities (of the 220 facilities that it owns) were leased to 30 tenants, five were under development, and the remaining assets were in the form of mortgage loans to four operators.
Deutsche Bank initiated Medical Properties Trust, Inc.